Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 2
1988 1
1989 4
1990 2
1991 1
1993 3
1994 3
1995 2
1996 7
1997 4
1998 9
1999 5
2000 10
2001 12
2002 10
2003 14
2004 11
2005 22
2006 23
2007 28
2008 41
2009 34
2010 50
2011 62
2012 69
2013 67
2014 62
2015 63
2016 54
2017 50
2018 47
2019 43
2020 48
2021 55
2022 52
2023 34
2024 29
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

867 results

Results by year

Filters applied: . Clear all
Page 1
[eUrology].
Stenzl A. Stenzl A. Urologe A. 2021 Sep;60(9):1115-1116. doi: 10.1007/s00120-021-01613-6. Epub 2021 Aug 25. Urologe A. 2021. PMID: 34432074 Free PMC article. German. No abstract available.
Defining Oligometastatic Bladder Cancer: A Systematic Review.
Bamias A, Stenzl A, Zagouri F, Andrikopoulou A, Hoskin P. Bamias A, et al. Among authors: stenzl a. Eur Urol Open Sci. 2023 Aug 22;55:28-37. doi: 10.1016/j.euros.2023.08.003. eCollection 2023 Sep. Eur Urol Open Sci. 2023. PMID: 37662704 Free PMC article. Review.
Editorial Comment.
Stenzl A. Stenzl A. J Urol. 2021 Jan;205(1):181-182. doi: 10.1097/JU.0000000000001345.01. Epub 2020 Oct 28. J Urol. 2021. PMID: 33112708 No abstract available.
The Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Oligometastatic Hormone-sensitive Prostate Cancer: A Post Hoc Analysis of ARCHES.
Armstrong AJ, Iguchi T, Azad AA, Villers A, Alekseev B, Petrylak DP, Szmulewitz RZ, Alcaraz A, Shore ND, Holzbeierlein J, Gomez-Veiga F, Rosbrook B, Zohren F, Haas GP, Gourgiotti G, El-Chaar N, Stenzl A. Armstrong AJ, et al. Among authors: stenzl a. Eur Urol. 2023 Aug;84(2):229-241. doi: 10.1016/j.eururo.2023.04.002. Epub 2023 May 12. Eur Urol. 2023. PMID: 37179240 Free article. Clinical Trial.
Enzalutamide and Prostate-Specific Antigen Levels in Metastatic Prostate Cancer: A Secondary Analysis of the ARCHES Randomized Clinical Trial.
Azad AA, Petrylak DP, Iguchi T, Shore ND, Villers A, Gomez-Veiga F, Alcaraz A, Alekseev B, Szmulewitz RZ, Holzbeierlein J, Rosbrook B, Ma J, Zohren F, El-Chaar NN, Haas GP, Stenzl A, Armstrong AJ. Azad AA, et al. Among authors: stenzl a. JAMA Netw Open. 2025 May 1;8(5):e258751. doi: 10.1001/jamanetworkopen.2025.8751. JAMA Netw Open. 2025. PMID: 40332939 Free PMC article. Clinical Trial.
Inmunotherapy in prostate cancer.
Anselmo da Costa I, Stenzl A, Bedke J. Anselmo da Costa I, et al. Among authors: stenzl a. Arch Esp Urol. 2019 Mar;72(2):211-222. Arch Esp Urol. 2019. PMID: 30855023 Free article. Review. English.
oDigital pathology biomarkers for guiding radiotherapy-based treatment concepts in prostate cancer - a systematic review and expert consensus.
Zamboglou C, Doncker W, Christoforou AT, Arcangeli S, Berlin A, Blanchard P, Bauman G, Campi R, Castro E, Choudhury A, Pra AD, Draulans C, Desai N, Ferentinos K, Francolini G, Gillessen S, Grosu AL, Rivas JG, Hoelscher T, Hruby G, Jereczek-Fossa BA, Kamran S, Kasivisvanathan V, Kishan AU, Kounnis V, Loblaw A, Martin J, Mastroleo F, Merseburger AS, Miszczyk M, Mohamad O, Ost P, Papatsoris A, Peeken JC, Sanguedolce F, Sargos P, Schmidt-Hegemann N, Seibert TM, Shelan M, Siva S, Soeterik TFW, Spratt DE, Stenzl A, Strouthos I, Sutera P, Supiot S, Tilki D, Tran PT, Tree AC, Tward J, Ürün Y, Vapiwala N, Waddle MR, Wegener E, Zilli T, Murthy V, Thieme AH, Spohn S. Zamboglou C, et al. Among authors: stenzl a. Radiother Oncol. 2025 Sep;210:111039. doi: 10.1016/j.radonc.2025.111039. Epub 2025 Jul 9. Radiother Oncol. 2025. PMID: 40645505 Review.
867 results